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Abstract
This article summarizes the proceedings of a symposium held at the 2005 Research Society on
Alcoholism meeting. The initial presentation by Dr. Wallner provided evidence that selected
GABAA receptors containing the δ subunit display sensitivity to low intoxicating ethanol
concentrations and this sensitivity is further increased by a mutation in the cerebellar α6 subunit,
found in alcohol-hypersensitive rats. Dr. Mameli reported that ethanol affects γ-aminobutyric acid
(GABA) function by affecting neural circuits that influence GABA release. Dr. Parsons presented
data from electrophysiological and microdialysis investigations that ethanol is capable of releasing
GABA from presynaptic terminals. Dr. Morrow demonstrated that systemic ethanol increases
neuroactive steroids in brain, the absence of which alters various functional responses to ethanol. Dr.
Criswell presented evidence that the ability of ethanol to increase GABA was apparent in some, but
not all, brain regions indicative of regional specificity. Further, Dr. Criswell demonstrated that
neurosteroids alone and when synthesized locally by ethanol act postsynaptically to enhance the
effect of GABA released by ethanol in a region specific manner. Collectively, this series of reports
support the GABAmimetic profile of acutely administered ethanol being dependent on several
specific mechanisms distinct from a direct effect on the major synaptic isoforms of GABAA receptors.
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For decades, the central nervous system (CNS) depression caused by ethanol has been
associated with γ-aminobutyric acid (GABA) mechanisms (Allan and Harris, 1987; Frye and
Breese, 1982; Harris, 1990; Liljequist and Engel 1982). Convincing evidence indicated that
the behavioral consequences of benzodiazepines (BZDs) and barbiturates were similar to those
induced by ethanol (Breese et al., 1983; Frye et al., 1979; White et al., 1997), Additionally,
BZDs and barbiturates enhanced ethanol-induced impairment of motor function (Martz et al.,
1983) and substituted for ethanol in discrimination investigations (Grant et al., 2000; Shannon
et al., 2004). Although BZDs and barbiturates were known to rely on GABAA-receptor function
(Harris, 1990; Ticku, 1989), these findings suggested that ethanol influenced the function of
GABA on GABAA receptors. In accord with this conclusion, GABAA receptor antagonists
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decreased the antipunishment action of ethanol (Koob et al., 1986, 1988; Liljequist and Engel,
1984) and decreased the sedative action of ethanol (Givens and Breese, 1990a; Harris, 1990;
Ticku, 1989), and a BZD-inverse agonist and a GABAA receptor antagonist decreased operant
responding for ethanol (Petry, 1995; Rassnick et al., 1993).
Nestoros (1980) reported that ethanol enhanced GABA-induced inhibition of cerebrocortical
neurons. In vivo electrophysiological studies reported regionally specific effects of ethanol on
cell firing (Bloom and Siggins, 1987; Givens and Breese, 1990a, 1990b). Particularly critical
was the demonstration that ethanol enhanced the inhibitory action of GABA on single unit
activity of medial septal neurons, but not from lateral septal neurons (Criswell et al., 1995;
Givens and Breese, 1990b)—a finding consistent with the regionally specific action of ethanol
on GABA effects on sleep time (Breese et al., 1984; McCown et al., 1986). Single-unit in vivo
recording from neurons at other brain sites showing differing effects of ethanol on GABA
responsiveness provided additional support for this view of regional specificity of ethanol on
GABA function (Criswell et al., 1995, 1993). Additionally, Wafford et al. (1991) reported that
transfection of the α1β1γ2 GABAA receptor subunit combination, which forms a type-1 BZD
receptor, allowed ethanol enhancement of GABA responsives, whereas other GABAA receptor
subunit combinations did not even at high ethanol concentrations—a finding suggestive that
the GABAA receptor subtype dictated the regional specificity to ethanol to enhance GABA
function. Other in vivo electrophysiological investigations demonstrated that the effect of
zolpidem, a type-1 BZD agonist, predicted the ability of locally applied ethanol to enhance the
effect of GABA on single-unit activity within specific regions of brain (Criswell et al., 1993,
1995, 1997).
However, in spite of the view that selected GABAA receptors with differing sensitivity to
ethanol supported the regional specificity of ethanol on GABA function in brain (Wafford et
al., 1991; Criswell et al., 1995, 1993), in vitro data began to accumulate that ethanol was not
directly influencing GABAA receptors on neurons from brain regions where ethanol influenced
GABA function in vivo (Palmer and Hoffer, 1990; Siggins et al., 1987b; White et al., 1990;
Givens and Breese, 1990a, 1990b). Frye et al. (1994) were unable to demonstrate an effect of
ethanol on GABA-gated currents from neurons isolated from medial septum, a brain site
previously shown to be sensitive to ethanol (Criswell et al., 1993, 1995; Givens and Breese,
1990a, 1990b). Peoples and Weight (1999) found an ethanol enhancement of GABA function
only at lethal concentrations. Later, Mori et al. (2000) and Criswell et al. (2003) reported that
ethanol did not have a reliable action to enhance GABA function from neurons isolated from
several regions of brain. These latter studies clearly discounted the view that ethanol acts
directly on type-1 BZD or the majority of other GABAA receptors to influence GABA function.
Consequently, given the lack of viability in vitro for a direct effect of ethanol affecting the
majority of GABAA receptors to enhance GABA function (Criswell et al., 2003; Frye et al.,
1994; Mori et al., 2000), it was concluded that the neural mechanism by which ethanol-
enhanced GABA function was not available to individual enzymatically isolated neurons—a
conclusion consistent with ethanol affecting neural mechanisms distinct from a direct action
on the majority of postsynaptic receptors (see Criswell et al., 2004, 2005a, 2005b). Thus, the
mechanism by which ethanol influences GABA function to enhance responsiveness in vivo in
a regionally specific manner required resolution.
The focus of presentations from this symposium is to introduce various actions of ethanol that
likely contribute to its GABAmimetic profile. These include data that implicate: (1) a direct
effect of ethanol on specific δ-containing GABAA receptor subtypes, (2) ethanol modulating
circuits which influence GABAergic transmission, (3) the ability of ethanol to induce
presynaptic GABA release, (4) an increase in neurosteroid presence in brain that can influence
GABAA receptor function, and finally (5) a regionally specific integration of ethanol’s
induction of brain neurosteroids enhancing the effect of GABA released by ethanol.
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ROLE OF δ SUBUNIT-CONTAINING GABAA RECEPTORS IN ACUTE
ETHANOL ACTIONS
Martin Wallner, H. Jake Hanchar, Paul Dodson, Thomas S. Otis, and Richard W. Olsen
GABAA Receptors as Alcohol Targets
GABAA receptors (GABAAR) have long been implicated in the intoxicating actions of ethanol
because GABAAR agonistic barbiturates and ethanol show striking similarities in their effects
on human behavior (Isbell et al., 1950). In addition, the GABAAR agonist muscimol potentiates
the sedative properties of alcohol, while the opposite effect, a reduction of ethanol-produced
sedation, is observed after administration of GABAAR blocking agents picrotoxin and
bicuculline (Liljequist and Engel, 1982). Furthermore, GABAAR agonistic BZDs share
similarities with ethanol action and have additive, possibly even synergistic (super-additive),
effects when taken together with ethanol. Using Cl− flux assays, a number of groups showed
that alcohol at low concentrations increased GABAAR-mediated Cl− flux in
synaptoneurosomes (Suzdak et al., 1986).
However, the identification of recombinant GABAAR subunit combinations sensitive to
relevant (3–30 mM) intoxicating concentrations of ethanol has been accomplished only fairly
recently (Sundstrom-Poromaa et al., 2002; Wallner et al., 2003) and we showed that the δ as
well as the β3 subunit is necessary for highly ethanol-sensitive receptors (Wallner et al.,
2003). These receptors have not received much attention because the focus of alcohol research
on GABAAR have been the more abundant synaptic (γ2 subunit-containing) GABAAR, that
are increased in their activity by alcohol, but only at anesthetic concentrations of >30 mM
ethanol (Mihic et al., 1997). In vivo GABAAR δ subunits are thought to be virtually exclusively
associated with α4 and cerebellar α6 subunits (Farrant and Nusser, 2005).
Why Are Extrasynaptic GABAA Receptors Appealing Targets for Alcohol and Anesthetics?
Delta subunit-containing GABAARs have been shown to be excluded from GABAergic
synapses, show slow desensitization, and are activated by ambient extracellular GABA
concentrations thought to be on the order of 0.1 to 1 μM (Farrant and Nusser, 2005). In contrast
to synaptic receptors that open only sporadically and briefly in response to presynaptic GABA
release, GABAARs containing the δ subunit give rise to a continuously active mode of
inhibition. Because of this continuous (tonic) activity, which more than compensates for their
low abundance and low GABA efficacy, these extrasynaptic receptors are critical for setting
overall neuronal excitability (Farrant and Nusser, 2005; Nusser and Mody, 2002). In addition,
and in marked contrast to γ2-containing receptors, δ subunit-containing GABAR show low
efficacy to GABA, that can be dramatically increased by anesthetics like etomidate, propofol,
and anesthetic concentrations of neuroactive steroids. These features make extrasynaptic
receptors excellent candidates for mediating not only the effects of some general anesthetics
but also attractive targets for ethanol actions (Fig 1A).
A Point Mutation in the BZD Site of the Cerebellar α6 GABAAR Subunit Leads to Increased
Alcohol-Induced Motor-Impairment
It was reported that alcohol nontolerant (ANT) rats, selected based on their high susceptibility
to the impairment of postural reflexes by ethanol (EtOH) and BZDs, have a point mutation in
the “BZD site” α6(R100Q) of the cerebellar GABA receptor α6 subunit (Korpi et al., 1993).
The α6R100Q mutation makes α6-containing receptors, when expressed with β2 and γ2
subunits, diazepam-sensitive (wild-type α6β2γ2-containing receptors are insensitive to
classical BZ agonists), and this likely explains the higher BZD sensitivity of ANT animals.
However, the reason(s) for the increased EtOH sensitivity of ANT rats remained unclear. The
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same α6(R100Q) point mutation has also been found enriched in the independently derived
“Sardinian alcohol nonpreferring” rats, (Saba et al., 2001). We reasoned that the identification
of the same “mutation” occurring in 2 independently derived rat lines selected for an alcohol
phenotype must be because of the selection of a fairly frequent naturally occurring α6(100Q)
allele. Supporting this view is the fact that the published rat genomic sequence contains the
α6-100Q allele and our finding that in commercial Sprague–Dawley rats (Charles River
Laboratories, Hollister, CA) the α6-100Q variant is a frequently occurring allele. We showed
that the α6-R100Q variant (in animals that were not selectively bred) is sufficient to cause
behavioral alcohol hypersensitivity at low alcohol doses in α6100QQ homozygous animals
(Hanchar et al., 2005). Most importantly we can show that the α6R100Q (ANT) mutation leads
to a further increase in the already high alcohol sensitivity of α6β3δ receptors (Fig. 1B), not
only in recombinant systems, but also in tonic currents from cerebellar granule cells from
animals homozygous for the α6R100Q allele (Hanchar et al., 2005). From our findings it would
be expected that selectively bred mutant α6-100QQ ANT rats should show alcohol-
supersensitive tonic currents in cerebellar granule cells. The reason(s) why this has not been
found remain unclear (Valenzuela et al., 2005).
The increase in alcohol sensitivity in the α4/6R100Q mutants (Fig. 1b) is unexpected because
alcohol sensitivity in GABAAR had been attributed to sites defined by mutations in
GABAAR transmembrane regions (Mihic et al., 1997) and it remains to be determined why a
mutation at a site in the protein important for BZD sensitivity has such dramatic effects on
alcohol sensitivity in these receptors.
We conclude that the direct activation of a subset of GABAAR (in particular those containing
the δ subunit) could be important for intoxicating ethanol effects experienced during social
alcohol consumption. This is consistent with the observation that δ subunit knockout animals
show multiple defects in behavioral responses to ethanol (Mihalek et al., 2001). Future
challenges will be to determine how important these receptors are when compared with other
potential alcohol targets and to determine the site and mechanism of alcohol action on these
uniquely alcohol-sensitive GABAA receptors. However, results have recently been reported
differing from those presented concerning the ethanol potentiation of GABA from δ-containing
receptors combined with α4 and β3 subunits (see Borghese et al., 2005). We are puzzled by
this report as low-dose alcohol has had a consistent effect on this GABAA receptor subtype in
our laboratory. The reason for the inability to reproduce low dose alcohol augmentation with
the human recombinant α4β3δ GABAA receptor expressed in oocytes and in a stable cell line
remains to be clarified.
MODULATION OF GABAergic INTERNEURONS BY ETHANOL
Manuel Mameli, Mario Carta, and C. Fernando Valenzuela
In recent years, brain slices and patch-clamp electrophysiological techniques have been used
to characterize the acute effect of ethanol on the function of GABAergic interneurons in the
hippocampus and cerebellum. In the hippocampus, kainate receptors are important modulators
of interneuronal excitability in the CA1 region. These receptors belong to the superfamily of
glutamate-gated ion channels, which also includes NMDA and AMPA receptors. Crowder et
al (2002) reported that 20 to 80 mM ethanol inhibits kainate receptor-mediated inhibition of
evoked inhibitory postsynaptic currents (IPSCs) in CA1 pyramidal neurons, indicating that
interneuronal kainate receptors are sensitive targets of ethanol. Consequently, a more detailed
characterization of this effect was performed. In addition to modulating evoked IPSCs,
activation of kainate receptors increases interneuronal firing, which robustly increases
spontaneous IPSC (sIPSC) frequency in pyramidal neurons. Carta et al (2003) found that
ethanol potently inhibits (IC50 = 4.4 mM) this kainate receptor–mediated effect at
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concentrations that can be achieved in blood after the ingestion of low amounts of ethanol.
This effect was secondary to an ethanol-induced inhibition of interneuronal firing in response
to kainate receptor activation by either exogenous agonist or synaptically released glutamate.
Interneuronal firing in response to activation of AMPA receptors or a voltage step was not
affected by ethanol. In the absence of kainate, ethanol (2–25 mM) did not significantly affect
the frequency or amplitude of sIPSCs in CA1 pyramidal neurons; however, a small (~20%)
but significant increase in sIPSC frequency was detected with 50 mM ethanol. Thus, ethanol
increases excitability of CA1 pyramidal neurons indirectly by inhibiting the kainate receptor–
dependent drive of GABAergic interneurons. We postulate that this effect of ethanol may
explain some of the paradoxical excitatory actions of this widely abused central nervous system
depressant.
We have also characterized modulation of cerebellar interneurons by ethanol. Recordings from
cerebellar granule cells revealed that ethanol increases GABAergic transmission to these cells
(Carta et al., 2004). These neurons receive GABAergic input in the form of phasic and tonic
currents from Golgi cells, an interneuronal subtype that is present in the granule cell layer of
the cerebellar cortex. Phasic currents are mediated by synaptic receptors containing α1βxγ
subunits, whereas tonic currents are mediated by extrasynaptic receptors containing α6βxδ
subunits. It was found that ethanol increases the frequency but not the amplitude of action
potential-dependent sIPSCs at a concentration as low as 20 mM. A similar finding was recently
reported by Hanchar et al (2005). Tonic currents were also increased at this concentration of
ethanol. However, in the presence of tetrodotoxin, ethanol failed to induce a significant change
in the tonic current amplitude, noise variance, or miniature IPSC (mIPSC) amplitude. The peak,
early phase, and spillover phase of inhibitory postsynaptic currents evoked by electrical
stimulation of the Golgi cells were also unaffected by ethanol. Importantly, loose-patch cell-
attached recordings from Golgi interneurons demonstrated that ethanol increases the
excitability of these neurons. Taken together, these findings indicate that ethanol does not
directly affect extrasynaptic GABAA receptors under our recording conditions (i.e., whole-cell
patch clamping at 31°C with a high chloride internal solution, in the absence of exogenous
GABA and GABA transporter inhibitors). Hanchar et al. (2005) reported that extrasynaptic
receptors display high sensitivity to ethanol under different experimental conditions and a
single amino acid difference (R100Q) in the sequence of the α6 GABAA receptor subunit
dramatically increases the ethanol sensitivity of these receptors (but see Valenzuela et al.,
2005). Thus, future experiments will be required to fully understand modulation by ethanol of
GABAergic transmission in cerebellar granule neurons.
Recently, we have begun to characterize modulation of molecular layer interneuronal function
by acute ethanol exposure. Recordings from Purkinje neurons indicate that ethanol increases
quantal GABA release from these inter-neurons without affecting postsynaptic GABAA
receptor function. These findings are in agreement with a recent report (Criswell and Breese,
2005a, 2005b). Two classes of interneurons are present in the molecular layer: basket cells and
stellate cells. We are currently investigating whether ethanol selectively affects 1 of these
interneuronal populations. These experiments are being carried out using glass stimulation
electrodes to selectively evoke IPSCs in response to GABA release from either basket cells or
stellate cells. Specifically, we are looking at the effect of ethanol on paired-pulse plasticity of
these events, as changes in this type of plasticity are inversely correlated to changes in the
probability of transmitter release. We are also studying the impact of the ethanol-induced
increase in quantal GABA release on the excitability of Purkinje neurons.
Collectively, the studies discussed above indicate that ethanol has diverse effects on
interneurons, even within the same region of the brain. In the granule cell layer of the
cerebellum, it increases GABAergic input in an action potential–dependent manner by
increasing spontaneous firing in Golgi cells (Carta et al., 2004; Hanchar et al., 2005). In the
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Purkinje cell layer of the cerebellum, it increases GABA release in an action potential–
independent manner (Criswell and Breese, 2005a, 2005b). In CA1 and CA3 pyramidal
hippocampal neurons from juvenile rats, subanesthetic concentrations of ethanol have little or
no effect on sIPSC frequency or amplitude (Carta et al., 2003; Galindo et al., 2005). However,
ethanol potently decreases the excitatory drive to CA1 interneurons, leading to disinhibition
of pyramidal neurons. Thus, the effects of ethanol on the function of GABAergic interneurons
are heterogeneous both in terms of mechanism and impact.
ACUTE AND CHRONIC ETHANOL ADMINISTRATION INCREASES GABA
RELEASE IN THE CENTRAL AMYGDALA: IN VITRO AND IN VIVO STUDIES
Loren H. Parsons, Marisa Roberto, and George R. Siggins
GABAergic transmission is sensitive to ETOH in distinct brain regions and is clearly involved
in the acute actions of ethanol and the development of ethanol tolerance and dependence.
Ethanol allosterically modulates the GABAA receptor complex and is believed to potentiate
the effects of GABA in some preparations, though inconsistent findings have contributed to a
continuing controversy over this hypothesis. For example, in several brain regions the acute
effects of ethanol on GABAA synaptic responses have been reported to be negligible (Nie et
al., 2000; Proctor et al., 1992), contingent on additional manipulations such as GABAB receptor
blockade (Nie et al., 2000; Wan et al., 1996) or stimulation in discrete segments of neuronal
afferents (Weiner et al., 1997a). In addition, the differential effects of acute and chronic ethanol
exposure on GABAergic function (Davis and Wu, 2001; Mihic, 1999) have further confounded
consensus on the effects of ethanol on GABAergic neurotransmission in the CNS.
In an effort to gain more insight into these issues we have conducted a series of experiments
that examined the effects of both acute and chronic ethanol on GABAA-mediated
neurotransmission in the central nucleus of the amygdala (CeA). The CeA, together with its
connections to the bed nucleus of the stria terminalis and nucleus accumbens is considered a
major component of the “extended amygdala,” a limbic forebrain complex hypothesized to be
a common neural substrate for the motivational effects of abused drugs and ethanol in
particular. The GABAergic system in the CeA has been implicated in the expression of
emotionality including behavioral states of fear and anxiety, as well as states associated with
consummatory responses. Moreover, the CeA is considered to be integrally involved in
mediating the behavioral effects of acute and chronic ethanol (Hyytia and Koob, 1995; Roberts
et al., 1996). Many of the findings discussed below have recently been published (Roberto et
al., 2003, 2004a, 2004b) and reviewed in a broader context (Siggins et al., 2005).
Using an intracellular recording procedure in CeA neurons of brain slices prepared from
ethanol-naive male Sprague–Dawley rats we found that acute superfusion with a medium
containing 44 mM ethanol clearly enhanced the amplitude of evoked GABA-mediated
inhibitory postsynaptic currents (IPSCs). The magnitude of this effect was responsive to
ethanol concentration (11–66 mM) with an apparent EC50 of 20 mM and was rapidly reversible
by removal of ethanol from the super-fusion medium. Ethanol was also found to decrease the
paired-pulse facilitation ratio of GABAA inhibitory IPSCs relative to the control condition.
Changes in paired-pulse facilitation ratio are inversely related to transmitter release such that
a reduction in paired-pulse facilitation is associated with an increased probability of transmitter
release. Thus, these data suggest that acute ethanol exposure increases GABA release in the
CeA of ethanol-naive rats. Using whole-cell patch-clamp measurements, ethanol was found to
increase the frequency of spontaneously occurring mIPSCs in a bicuculline-sensitive manner,
suggestive of an ethanol-induced enhancement of presynaptic GABA release. In addition,
ethanol increased the amplitude of mIPSCs in approximately half the neurons evaluated,
suggesting an influence of ethanol on postsynaptic mechanisms of some, but not all neurons.
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In subsequent experiments, we sought to evaluate the effect of ethanol on GABA release in
the CeA using an in vivo preparation. In these experiments ethanol was locally delivered to
the CeA of ethanol-naïve rats by retrodialysis, and concurrent changes in dialysate GABA
levels were determined using capillary electrophoresis coupled with laser-induced
fluorescence. Based on previous work by others (Robinson et al., 2000), a 10% retrodialysis
efficiency was estimated in this experiment, and thus the ethanol concentrations delivered to
the tissue immediately surrounding the dialysis probe were approximately 10 to 100 mM, with
the concentration declining sharply as a function of distance from the probe membrane because
of dilution in the interstitial space. With this protocol, we observed that local ethanol
administration induced a significant and dose-dependent (0.1–1.0 M) increase in dialysate
GABA levels to maximum of approximately 200% of baseline (see example in Fig. 2).
Interestingly, there was no effect of ethanol on glutamate, glycine, or taurine levels in these
same dialysate samples indicating a selective effect of ethanol on GABA release under these
conditions. Consequently, these findings provide important in vivo support for the
electrophysiological observations made in the slice preparation, which collectively indicate
that acutely administered ethanol increases GABA release in the CeA of ethanol-naïve rats.
Chronic ethanol exposure is known to induce many long-term adaptations in CNS function
and some data suggest that chronic ethanol consumption reduces GABA ergic function thereby
producing tolerance to many of the presumed GABA-mediated behavioral effects of ethanol.
Based on these observations, we evaluated alterations in CeA GABA function in animals given
chronic ethanol treatment (CET) through long-term ethanol vapor inhalation. Ethanol vapor
concentrations were titrated to maintain blood alcohol levels of 150 to 200 mg% for more than
14 days in male Sprague–Dawley rats. Subsequent electrophysiological and microdialysis
measures were made in the CeA 2 to 8 hours after removal from the ethanol vapor, a time frame
during which significant signs of ethanol withdrawal have been observed using this paradigm
(Macy et al., 1996). We found that the amplitude of evoked GABAA-mediated IPSP/Cs was
significantly enhanced in the CeA of rats previously exposed to CET relative to ethanol-naïve
controls. Moreover, both the frequency and amplitude of spontaneously occurring mIPSCs
were robustly enhanced in CET rats relative to controls and collectively these observations
suggest that basal GABAergic transmission is enhanced following CET. This was supported
by the observation of significantly higher baseline dialysate GABA levels collected from the
CeA of CET rats compared with ethanol naïve rats. Baseline dialysate levels of glycine and
taurine were unaltered by CET, though baseline glutamate levels were significantly increased
in CeA microdialysates collected from CET rats. Interestingly, acute ethanol exposure
enhanced the amplitude of evoked GABAA-mediated IPSCs to a similar extent in CeA slices
from CET and ethanol-naïve rats, and this similarity was observed across a range of stimulus
intensities. In fact, estimated EC50s for the ethanol-induced enhancement of evoked IPSCs
amplitude was 18 and 20 mM for the CET and naïve groups, respectively. Ethanol was also
found to produce a similar decrease in paired-pulse facilitation ratios and a similar increase in
the frequency of spontaneous mIPSCs in the CeA of CET and naïve rats. These observations
suggest that CET does not induce tolerance to ethanol-induced increases in GABA release in
the CeA. This was supported by in vivo microdialysis measures in which local ethanol
administration significantly enhanced GABA levels in CeA dialysates collected from CET rats,
despite the nearly 5-fold increase in baseline dialysate GABA levels in these animals. As in
ethanol-naïve rats, local ethanol administration did not alter glycine or taurine levels in CeA
dialysates from CET rats, though a significant and ethanol concentration–dependent increase
in dialysate glutamate levels was observed.
Collectively these findings indicate that ethanol increases GABA transmission in CeA neurons.
The consistent observations of ethanol-induced decreases in paired-pulse facilitation ratios,
increases in mIPSC frequencies and increased GABA levels in CeA dialysates indicate that
acute ethanol increases presynaptic GABA release. In addition, ethanol increased the amplitude
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of mIPSCs in approximately half the neurons evaluated, suggesting an influence of ethanol on
postsynaptic mechanisms of some, but not all, neurons. The effects of acute ethanol on GABA
transmission were preserved in CET rats, indicating a lack of tolerance to the stimulatory effects
of ethanol. However, the robust increase in basal IPSCs, mIPSC frequency and baseline
dialysate GABA levels following CET suggests a novel neuroadaptive mechanism that may
be involved in the development of ethanol dependence.
GABAERGIC NEUROACTIVE STEROIDS MODULATE SELECTIVE ETHANOL
ACTIONS: MECHANISMS AND SIGNIFICANCE
A. Leslie Morrow, Shannon N. Penland, and Rahul T. Khisti
Ethanol is anxiolytic, sedative/hypnotic, and anticonvulsant and causes impairments in
cognitive processing (for a review, see Morrow et al., 2001). These effects of acute ethanol
administration are remarkably similar to the effects of 3α,5α-reduced neurosteroids as well as
BZDs and barbiturates—all modulators of GABAA receptors. The neuroactive steroids 3α-
hydroxy-5α-pregnan-20-one (3α,5α-THP) and 3α,21-dihydroxy-5α-pregnan-20-one (3α,5α-
THDOC) are potent modulators of GABAA receptor inhibition (Majewska et al., 1986; Morrow
et al., 1987). We have made a series of discoveries that led us to propose that endogenous
neuroactive steroids play an important role in the complex and controversial interactions
between ethanol and GABAA receptors.
Systemic ethanol administration dramatically elevates both plasma and brain 3α,5α-THP and
3α,5α-THDOC levels in male and female rats (Barbaccia et al., 1999; Morrow et al., 1999;
O’Dell et al., 2004). In male rats, circulating 3α,5α-THP levels increased 600% above handling-
habituated saline-injected control rats (Morrow et al., 1999). Cerebral cortical 3α,5α-THP
levels were elevated approximately 700% above controls. Female rats were tested during the
estrus phase of the estrous cycle when both circulating and cerebral cortical 3α,5α-THP levels
are substantially higher than male rats. Ethanol increased circulating 3α,5α-THP levels by
157% and cerebral cortical 3α,5α-THP levels by 234% in female rats. 3α,21-Dihydroxy-5α-
pregnan-20-one and its precursor deoxycorticosterone are also elevated dramatically in plasma
and brain following systemic ethanol administration (Barbaccia et al., 1999; Khisti et al.,
2005). These increases in brain 3α,5α-THP and 3α,5α-THDOC levels are sufficient to enhance
GABA-mediated neurotransmission and produce anxiolytic and anticonvulsant effects
(VanDoren et al., 2000). We have explored whether increased brain concentrations of
neuroactive steroids modulate the behavioral effects of ethanol discussed above.
Behavioral and Functional Effects of Ethanol Modulated by Endogenous Neuroactive
Steroids
Systemic administration of moderate doses of ethanol increases both plasma and brain levels
of 3α,5α-THP and 3α,5α-THDOC and their precursors progesterone and DOC in rodents, in a
time-dependent and concentration-dependent manner (Barbaccia et al., 1999; Khisti et al.,
2005; Morrow et al., 1999; O’Dell et al., 2004; VanDoren et al., 2000). Ethanol-induced
elevations of GABAergic neuroactive steroids clearly contribute to many behavioral effects of
ethanol in rodents. Neuroactive steroids modulate anticonvulsant effects (VanDoren et al.,
2000), sedation (Khisti et al., 2003), impairment of spatial memory (Matthews et al., 2002;
Morrow et al., 2001), anxiolytic-like (Hirani et al., 2005), antidepressant-like (Hirani et al.,
2002), and reinforcing properties of ethanol in rodents (Janak et al., 1998; Morrow et al.,
2001). Each of these behavioral responses is inhibited by pretreatment with the biosynthesis
inhibitor finasteride and/or by previous adrenalectomy. Importantly, administration of the
immediate precursor of 3α,5α-THP restores effects of ethanol in adrenalectomized animals,
showing that brain synthesis of neuroactive steroids modulates effects of ethanol (Khisti et al.,
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2003). Additionally, VanDoren et al. (2000) were able to block the effects of moderate
concentrations of ethanol on medial septal neurons and Tokunaga et al. (2003) demonstrated
a reduction of ethanol activity in the hippocampus by minimizing the production of
neurosteroids. Taken together, these studies suggest that elevations in neuroactive steroids are
responsible for many of the GABAergic effects of ethanol in vivo and the effects of neuroactive
steroids may determine sensitivity to the behavioral effects of ethanol.
Neurosteroids Do Not Affect All Ethanol-Mediated Behaviors
In contrast to the role of neurosteroids in many ethanol-induced behaviors, ethanol-induced
ataxia and motor incoordination are insensitive to the effects of finasteride and adrenalectomy
in rats. Although finasteride (25–50 mg/kg) reduces (VanDoren et al., 2000) and adrenalectomy
prevents (Khisti et al., 2003) ethanol-induced elevations in 3α,5α-THP levels in the cerebral
cortex, these procedures did not prevent ethanol-induced impairment of the severity of
intoxication or the loss of aerial righting or ataxia in the rotarod task up to 60 minutes following
ethanol administration (Khisti et al., 2003). Although ethanol-induced impairment of motor
behavior is thought to involve GABAergic neurotransmission, such impairment is more
prominent at time points (<20 minutes) when ethanol-induced increases in cortical 3α,5α-THP
levels are not yet present. As procedures that reduce 3α, 5α-THP levels did not prevent ethanol
impairment of motor coordination using several measures of motor impairment, it is likely that
elevated GABAergic neuroactive steroid biosynthesis does not contribute to the motor-
incoordinating effects of ethanol.
Suppression of Neurosteroid Responses Following Chronic Ethanol Exposure
It is well known that chronic ethanol stress results in adaptation of the hypothalamus–pituitary–
adrenal (HPA) axis resulting in decreased levels of corticosterone in rats (Spencer and
McEwen, 1990). Repeated exposure to alcohol also blunts the response of the HPA axis to a
second drug challenge with a reduction in corticotropin-releasing factor and
adrenocorticotrophin levels (Lee et al., 2001). Similar alterations in the HPA axis are observed
in actively drinking or alcohol-dependent human subjects (Adinoff et al., 2005; Wand and
Dobs, 1991). In line with these observations, chronic ethanol consumption in rats results in
blunted elevation of cerebral cortical 3α,5α-THP (Morrow et al., 2001) and plasma and brain
DOC levels (Khisti et al., 2005) following ethanol challenge. These findings suggest that there
is tolerance to ethanol-induced increases in neuroactive steroid levels. Although decreases in
brain neurosteroid levels were concomitant with decreases in plasma neurosteroid levels, it is
likely that the observed decreases in 3α,5α-THP and DOC levels were dependent on blunted
HPA axis activity. Thus, adaptations of the HPA axis may underlie tolerance to effects of
ethanol that are mediated by the GABAergic neuroactive steroids.
Mechanism of Ethanol-Induced Increases in Neurosteroids
We investigated the hypothesis that ethanol could alter steroidogenic enzyme activity in rat
brain and adrenal minces. Basal neurosteroidogenic enzyme activity was different in rat brain
and adrenal gland. Fresh brain or adrenal tissue minces were incubated with radiolabeled
steroid precursor and conversion to radiolabeled steroid product was monitored. 5α-Reductase
enzyme activity was assessed by measuring total conversion of [14C]progesterone to [14C]
dihydroprogesterone (DHP) and [14C]3α, 5α-THP. 5α-Reductase activity peaked at 10% to
12% conversion after 60 minutes in the cortex, cerebellum, and adrenal gland. The OB+T had
a higher basal activity compared with other tissues (24% conversion). The 5α-reductase
enzyme inhibitor finasteride (0.1 μM) significantly reduced the activity of the 5α-reductase
enzyme only in the OB+T and adrenal gland. Ethanol did not alter 5α-reductase enzyme activity
in rat brain or adrenal gland minces. The effect of ethanol on 5α-reductase activity was
investigated in minces of rat cerebral cortex, cerebellum, OB+T, and adrenal gland. Ethanol
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(10–100 mM) did not alter total percent conversion of [14C]progesterone to [14C]DHP above
basal levels in these tissues.
3α-Hydroxysteroid dehydrogenase (HSD) reductive enzyme activity was assessed by
measuring total conversion of [14C]DHP to [14C]3α,5α-THP. 3α-Hydroxysteroid
dehydrogenase reductive activity was highest in the OB+T (44.5 ± 4.4%) and adrenal gland
(29.9 ± 5.1%). The 3α-HSD enzyme inhibitor indomethacin (0.2 μM) significantly reduced the
reductive activity of the 3α-HSD enzyme in all regions. Ethanol (10–100 mM) increased the
conversion of [14C]5α-DHP to [14C]3α,5α-THP by 30.0 ± 3.6% in the OB+T, but had no effect
in the adrenal gland. In the cerebral cortex and cerebellum, ethanol did not increase 3α-HSD
activity to the extent observed in the OB+T. Although there was a trend toward increased
activity in the cerebral cortex and cerebellum in the presence of ethanol, the data were not
statistically significant except for 1 dose (25 mM) in the cerebellum because of the small size
of the changes (10%–15% above basal). We tested the effect of fluoxetine as a positive control
as previous studies showed that fluoxetine decreased the Km of a recombinant 3α-HSD enzyme
(Griffin and Mellon, 1999). Fluoxetine increased the activity of 3α-HSD enzyme in the OB+T
and adrenal gland and this effect was blocked by the 3α-HSD inhibitor indomethacin.
The 3α-HSD enzyme possesses bidirectional activity so we examined the effect of ethanol on
the oxidative activity of 3α-HSD. 3α-Hydroxysteroid dehydrogenase oxidative enzyme activity
was assessed by measuring total conversion of [3H]3α,5α-THP to [3H]DHP. In the oxidative
direction, basal activity rates were 17.0 ± 2.3% total conversion in the OB+T and 24.4 ± 3.9%
in the adrenal gland and were sensitive to indomethacin. The cerebral cortex exhibited less
3α-HSD oxidative activity (9.9 ± 1.4%) and was insensitive to indomethacin. Ethanol did not
alter the total percent conversion of [3H]-ALLO to [3H]DHP in rat OB+T or adrenal gland. An
increase in the reductive activity of the 3α-HSD with no change in the oxidative direction would
cause a greater conversion of 5α-DHP to ALLO. This effect could contribute to ethanol-
induced increases in brain 3α,5α-THP levels. Indeed, the increased reductive activity of 3α-
HSD would be predicted to increase brain levels of both 3α,5α-THP and 3α,5α-THDOC.
Summary
We propose that the data reviewed in this chapter represent compelling evidence that 3α,5α-
THP produced in response to systemic ethanol administration contributes to some, but not all
effects of ethanol associated with modulation of GABAA receptors. These studies demonstrate
an essential correlation between the time course of ethanol-induced 3α,5α-THP production in
the brain and specific effects of ethanol. Furthermore, the anxiolytic, anticonvulsant, cognitive
impairing, and inhibitory effects of ethanol on spontaneous neural activity in 2 brain regions
were completely prevented by a key inhibitor of steroid biosynthesis or adrenalectomy. In
contrast, ethanol-induced motor incoordination is not affected by either steroid synthesis
inhibition or adrenalectomy. These data are consistent with the hypothesis that 3α,5α-THP
contributes to ethanol action and this interaction represents an important mechanism of ethanol
action.
NEUROSTEROID SYNERGISM OF THE EFFECT OF GABA RELEASED BY
ETHANOL: RELEVANCE TO THE GABAMIMETIC PROFILE OF ETHANOL
Hugh E. Criswell, Z. Ming, and George R. Breese
While selected BZD-insensitive GABAA receptors, which have a limited localization in brain
(Peng et al., 2002), have been reported to support the action of ethanol on GABA
responsiveness in specific regions of brain (Sundstrom-Poromaa et al., 2002; Wallner et al.,
2003), there is controversy concerning these findings (see Borghese et al., 2005). Additionally,
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unlike BZDs and barbiturates, ethanol does not appear to act directly on most other GABAA
receptor subtypes to enhance GABA function (Criswell et al., 2003; Mori et al. 2000; Peoples
and Weight, 1999; Siggins et al., 1987b; see review by Criswell and Breese, 2005a, 2005b;
Siggins et al., 2005). Therefore, for systemic ethanol to display its GABAmimetic profile, it
is hypothesized that ethanol affects mechanisms associated with GABA function distinct from
a direct effect on the majority of postsynaptic GABAA receptors (Criswell and Breese,
2005a, 2005b). These neural mechanisms must be capable of supporting ethanol depression of
neural rate (Givens and Breese, 1990b) and the action of ethanol on evoked IPSCs (Roberto
et al., 2003; Weiner et al., 1997a) from some, but not all, neurons within and across brain
regions (Breese et al., 1984; Givens and Breese, 1990a, 1990b; McCown et al., 1986; Weiner
et al., 1997a). Current evidence is conistent with 2 indirect actions of ethanol having a major
influence on GABA function. One relates to the ability of ethanol to increase release of GABA
from presynaptic terminals (Carta et al., 2003; Crowder et al., 2002; Roberto et al., 2003;
Ziskind-Conhaim et al., 2003) and the second relates to the action of ethanol to increase
synthesis of GABAmimetic neuroactive steroids (Morrow et al. 1999, 2004, 2001; O’Dell et
al., 2004; Sanna et al., 2004).
Effect of Ethanol on GABA Release
In very early work (Bloom and Siggins, 1987; Siggins et al., 1987a, 1987b; see review by
Siggins et al., 2005), a possible presynaptic action of ethanol was proposed. Consistent with
this view, Marszalec et al. (1998) found that perfusion of 100 mM ethanol augmented
GABAA receptor–mediated IPSCs from rat cortical neurons, even though the effect of GABA
applied to the neuron was not altered. Further, Melis et al. (2002) found that ethanol increased
the frequency of miniature mIPSPs from ventral tegmental neurons, a finding in accord with
GABA release, but in apparent conflict with data collected with microdialysis where ethanol
did not increase GABA in the perfusate (Cowen et al., 1998). Additionally, reports found that
ethanol increased mIPSPs from hippocampal neurons (Carta et al., 2003; Roberto et al.,
2003; Sanna et al., 2004), from brain stem motor neurons (Sebe et al., 2003), and from neurons
in slices of rat spinal cord (Ziskind-Conhaim et al., 2003). Most importantly, Roberto et al.
(2003, 2004a) provided evidence that ethanol not only enhanced the effect of stimulus-induced
GABA-mediated IPSPs and mIPSCs from neurons in slices from the central nucleus of the
amygdala, but that ethanol caused release of GABA in vivo from this brain site into
microdialysates (Roberto et al. 2004b)—clear evidence that ethanol can facilitate release of
GABA.
In addition to the work on mIPSCs performed in slices (see Carta et al., 2004; Nie et al.,
2004; Roberto et al., 2003, 2004a), the use of mechanically dissociated neurons that have
terminals attached (see Akaike and Moorhouse, 2003) has allowed confirmation of the
conclusion that ethanol indeed has the ability to release GABA directly from presynaptic
terminals. Utilizing this approach, Criswell et al. (2004) provided evidence that ethanol
increased the frequency of mIPSCs from cerebellar Purkinje neurons. Zhu and Lovinger
(2004) reported similar ethanol enhancement of the frequency of mIPSCs from neurons
mechanically dissociated from the basolateral amygdala. As these mIPSCs were blocked by
bicuculline, postsynaptic GABAA receptors were being activated by the ethanol-induced
release of GABA.
The demonstrated presynaptic action of ethanol to increase frequency of GABA-induced
mIPSCs (Carta et al., 2003; Criswell et al., 2004; Roberto et al., 2003, 2004a; Zhu and Lovinger,
2004) supports the view that ethanol can affect a mechanism related to GABA function distinct
from a postsynaptic action on GABAA receptors. These findings can explain the positive
interaction of ethanol with modulators of GABAA receptor function, such as barbiturates and
BZDs (Akaike et al., 1990; Puia et al., 1991), by these latter drugs enhancing the effect of the
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increased GABA release by ethanol. For the present, the mechanism by which ethanol induces
release of GABA from some, but not all, terminals is uncertain, but is a finding that should
receive attention. The next question that arose was whether another mechanism or action of
ethanol could contribute to the GABAmimetic profile of ethanol by affecting the degree of
responsiveness to GABA released by ethanol.
Involvement of Neurosteroids
Progesterone released from the adrenal serves as a precursor for central neurosteroids (see
Barbaccia et al., 2001; Mellon et al., 2001). Acute administration of ethanol activates the HPA
axis and increases plasma precursors for neurosteroids resulting in their elevation in brain
(Barbaccia et al., 1999; Morrow et al., 2001)—a change reduced by adrenalectomy (Khisti et
al., 2002; 2003) and by combining adrenalectomy and gonadectomy (Follesa et al., 2005;
O’Dell et al., 2004). However, evidence has been provided that neurosteroids can be produced
in brain by de novo synthesis (Follesa et al., 2005), distinct from precursors produced by the
adrenals (Khisti et al., 2003). Based on the findings that reducing neurosteroid content in brain
minimized sedation and other actions of ethanol, Morrow et al. (1999, 2001, 2004) suggested
that the increase in neurosteroids following acute ethanol administration contributes to its
actions.
While adrenalectomy reduces neurosteroids (Khisti et al., 2002, 2003; O’Dell et al., 2004), this
treatment reduces, but does not eliminate, the ethanol’s ability to influence CNS function
(Bowers et al., 1991; Khisti et al., 2003). The physiological significance of neurosteroids being
produced in brain by de novo synthesis (Follesa et al., 2005; Sanna et al., 2004), distinct from
precursors produced by the adrenals (Khisti et al., 2003), has yet to be resolved. Important to
this discussion is that the neurosteroids, allopregnanalone and tetrahydro deoxycorticosterone,
are potent allosteric modulators of GABA responsiveness from GABAA receptors, having this
action at nanomolar concentrations (Criswell et al., 2003; Schwabe et al., 2005) on some, but
not all, GABAA receptor subtypes (Belelli et al., 2002; Bianchi and Macdonald, 2003; Lambert
et al., 2001; 2003; Stell et al., 2003).
A clue to the mechanism by which the ethanol-induced increase in neurosteroids influences
GABA function was a study by Kang et al. (1998) who noted that the presence of neurosteroid-
enhanced evoked IPSCs from hippocampal neurons. Further, alphaxalone and other
neurosteroids have been shown to increase the decay time of mIPSCs associated with the
GABA released by ethanol (Criswell and Breese, 2005a; Sanna et al., 2004; Vicini et al.,
2002). These observations indicate that the neuosteroid is acting postsynaptically to enhance
GABA responsiveness. The endogenous level of neurosteroids increased by pharmacologically
relevant doses of ethanol is consistent with these compounds contributing to the
pharmacological activity of ethanol by enhancing the action of GABA released by ethanol.
Regional Specificity of Ethanol on Presynaptic Release of GABA and Neurosteroids
Involvement
Several studies have demonstrated that ethanol does not enhance GABA function from all brain
regions in vivo (Criswell et al., 1993; Givens and Breese, 1990b). Studies from neurons from
differing brain regions in vitro have demonstrated that ethanol does not have equivalent effects
to increase mIPSCs from neurons (Criswell et al., 2004). For example, unlike data from
cerebellar Purkinje neurons (Criswell et al., 2004, 2005a; Ming et al., 2006) and basolateral
amygdala neurons (Zhu and Lovinger, 2004), ethanol did not increase the frequency of mIPSCs
from mechanically dissociated cerebrocortical neurons (Criswell et al., 2004; Criswell and
Breese, 2005a). Likewise, ethanol did not enhance IPSCs from some hippocampal neurons
(Ariwodola and Weiner, 2004; Weiner et al., 1997a). Consequently, the means by which
ethanol has this regional selectivity to release GABA from some, but not all, terminals is
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uncertain, but must be resolved to provide a clear understanding of the GABAmimetic profile
of ethanol.
Previous work has demonstrated the specificity of neurosteroids to enhance GABA function
from specific GABAA receptor subtypes (see Belelli et al., 2002; Bianchi and Macdonald,
2003; Lambert et al., 2001, 2003; Spigelman et al., 2003; Stell et al, 2003; Wallner et al.,
2003). Thus, this differing responsiveness of GABAA receptors to neurosteroid enhancement
of GABA could conceivably contribute to the regional specificity of ethanol on GABA
function. Furthermore, a differing presence of neurosteroids in specific regions of brain could
be another means by which regional selectivity of ethanol could be realized. In this respect,
the enzymes responsible for synthesizing neurosteroids have a differential distribution in brain
(Dupont et al., 1994; Khanna et al., 1995; Korneyev et al., 1993; Pelletier et al., 1994). Thus,
in addition to the regional effect of ethanol to release GABA, the differential synthesis of
neurosteroids in differing brain regions and the differing response of GABAA receptor subtypes
to neurosteroids can contribute to the regional specificity of ethanol to affect GABA function.
Integration of Ethanol Facilitation of GABA Release With the Postsynaptic Action of
Neurosteroids Increased by Ethanol
The previous observations indicated that ethanol enhances GABA release and that
neurosteroids increased by ethanol enhance GABA responsiveness in a regionally specific
manner. The integration of these actions of ethanol presumably contributes to regional
differences in ethanol’s actions on GABA function within brain to contribute to its
GABAmimetic profile. Brain areas where ethanol-induced enhancement of GABA release is
prominent and where neurosteroids synthesized locally enhance GABA responsiveness most
likely provide a major contribution to ethanol’s GABAmimetic profile. In contrast, brain
regions, where these processes do not occur, would not be likely to contribute to the
GABAmimetic action of ethanol. Thus, the integration across brain regions of the magnitude
of GABA release, with the increasing influence of neurosteroids over time on the
responsiveness of the released GABA, provide a logical basis for the regional specificity of
ethanol to affect GABA function.
The observation by Sanna et al (2004) that ethanol can increase synthesis of neurosteroids in
a slice has provided a means to measure the integration of neurosteroid involvement on the
effect of GABA released by ethanol. Using this approach, the overall contribution of the
integration of these actions of ethanol will become apparent across brain regions. An example
of this approach demonstrating the action of neurosteroid synthesized during incubation on the
degree of enhancement of GABA responsiveness is provided in Fig. 3.
OTHER CONSIDERATIONS
Collectively, this symposium summarizes the involvement of several factors which contribute
to the GABAmimetic profile of ethanol. Integration of these factors is likely to promote the
regionally specific action of ethanol to influence GABA function. Nonetheless, clarification
of the involvement of other mechanisms that influence GABA function will need to be
integrated with GABA release and neurosteroid involvement before the means by which
ethanol induces modification of GABA function in differing brain regions will be fully
understood. Particularly, the involvement of ethanol on phosphorylation mechanisms (Weiner
et al., 1997b; 1994a,b) and the modification of GABA release by GABAB receptors (Wan et
al., 1996; Weiner et al., 1997a; Wu et al., 2004) or neurotransmitters other than GABA that
influence release of GABA needs further clarification (Nie et al., 2004; see Siggins et al.,
2005). A particularly important issue is whether involvement of these various mechanisms that
influence GABA function differ across brain regions. Finally, as recently reported results (see
Borghese et al., 2005) concerning ethanol potentiation of GABA from δ-containing receptors
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combined with the α4 subunit differs from those presented in this symposium, the basis of this
disparity will need future clarification so the role of this GABAA receptor subtype in the
GABAmimetic profile of ethanol can be clearly delineated.
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(a) Proposed role of synaptic and extrasynaptic receptors. Synaptic receptors have low potency
and high efficacy, whereas extrasynaptic δ subunit-containing receptors show high potency
and low efficacy. GABAA receptor–specific anesthetics (etomidate, propofol, neurosteroids)
can dramatically increase the low efficacy of extrasynaptic receptors (modified from Wallner
et al., 2003). (b) The α4/6-R100Q mutation leads to a further increase in alcohol sensitivity of
α6β3δ receptors. Original traces that illustrates the dramatic increase in ethanol sensitivity
(concentrations indicated are in mM) of recombinant α4/6R100Qβ3δ receptors expressed in
Xenopus oocytes (lower panel), particularly at low intoxicating (3–30 mM) alcohol
concentrations. The threshold for activation of α4/6β3δ receptors is around 3 mM in α4β3δ
receptors, a concentration almost 6 times lower than 17 mM, the legal driving limit in
California, and even lower in mutant a4/6R100Qβ3δ receptors. Black bar indicates the
application of 300 nM γ-aminobutyric acid. (Modified from Hanchar et al., 2005.)
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Effect of local ethanol (EtOH) administration on dialysate γ-aminobutyric acid (GABA) levels
collected from the central nucleus of the amygdala (CeA) of EtOH-naive and chronic EtOH
treatment (CET) rats. Stimulatory effect of acute and chronic EtOH administration on
interstitial GABA levels in the CeA of the rat as determined by in vivo microdialysis. Chronic
EtOH treatment resulted in a significant increase in baseline dialysate GABA levels collected
from the CeA of CET rats (n =7) compared with EtOH-naïve rats (n =11). Subsequent local
EtOH administration by retrodialysis (1.0 M perfusate EtOH concentration) significantly
increased dialysate GABA levels in both EtOH-naive and CET animals (time 0–30 minutes).
Dialysate GABA levels returned to baseline levels upon removal of perfusate EtOH (time 30–
70 minutes). See text and Roberto et al. (2004a) for further details.
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Increased decay time of mIPSCs of cerebellar Purkinje neurons with extended ethanol
incubation. Cerebellar slices were incubated with ethanol (50 mM) for 30 minutes and decay
times [τslow] of miniature inhibitory postsynaptic current (mIPSCs) from Purkinje neurons
determined. Decay time of mIPSCs was significantly increased (p<0.05) at 20 and 30 minutes
of ethanol incubation—a change minimized by finasteride indicative that the decay time of the
mIPSCs related to steroidogenesis by ethanol. N =10 to 12 neurons.
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